EMT induction in human breast cancer cells could enhance drug resistance and contribute to maintaining the stemness of CSCs including the CD44+/CD24− phenotype and the mammosphere forming ability13, while the CD44+/CD29+ cells in squamous cell carcinoma showed properties of CSCs and EMT12. This evidence concerns the gene CD44 and breast carcinoma.